BioSpace News Archive

AXIM® Biotechnologies, Inc., a world leader in cannabinoid research and product development, announced that the United States Patent and Trademark Office has issued the Company a new Notice of Allowance for a patent on a suppository composition comprising cannabinoids.

MannKind Corporation announced that Anthony Hooper will join its Board of Directors, effective January 1, 2020.

Aesthetic Medical International Holdings Group Limited, a leading provider of aesthetic medical services in China, announced that the Company will host its earnings conference call on Tuesday, November 26, 2019 at 8:00 am Eastern Time to discuss the Company’s financial results of the third quarter ended September 30, 2019.

The offering is expected to close on or about November 25, 2019, subject to the satisfaction of customary closing conditions.

Pacitti is focused on enabling providers with faster, more precise, less invasive and more efficient healthcare solutions, to improve patient experiences and further the impact of technology on the U.S. healthcare system.

CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures.

High-tech biopharma company partnering with childcare leader, Bright Horizons, to ensure working parents have the support they need to achieve their family and career ambitions

Broadly neutralising antibodies are antibodies that can recognise and block the entry of different strains of HIV into healthy cells.

LightIntegra Technology announced today that it has appointed Dr. Andrew Heaton, to its board of directors effective November 21, 2019.

Onconova Therapeutics, Inc. announced that it has priced a public offering of an aggregate of 55,000,000 shares of Onconova’s common stock, together with accompanying common stock warrants, at a public offering price of $0.20 per share and associated warrant.